[HTML][HTML] The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based …
DM Oliansky, M Czuczman, RI Fisher, FD Irwin… - Biology of blood and …, 2011 - Elsevier
Clinical research published since the 2001 evidence-based review on the role of
hematopoietic stem cell transplantation (SCT) in the treatment of diffuse large B cell …
hematopoietic stem cell transplantation (SCT) in the treatment of diffuse large B cell …
High‐dose therapy with autologous stem cell transplantation versus chemotherapy or immuno‐chemotherapy for follicular lymphoma in adults
M Schaaf, M Reiser, P Borchmann… - Cochrane Database …, 2012 - cochranelibrary.com
Background Follicular lymphoma (FL) is the most common indolent and second most
common Non‐Hodgkins lymphoma (NHL) in the Western world. Standard treatment usually …
common Non‐Hodgkins lymphoma (NHL) in the Western world. Standard treatment usually …
Use of rituximab in diffuse large B‐cell lymphoma in the salvage setting
C Gisselbrecht - British journal of haematology, 2008 - Wiley Online Library
The addition of rituximab (R) to CHOP (cyclophosphamide, doxorubicin, vincristine,
prednisone) chemotherapy was a milestone in the development of front‐line therapy for …
prednisone) chemotherapy was a milestone in the development of front‐line therapy for …
[图书][B] Nuclear medicine therapy
JF Eary, W Brenner - 2007 - api.taylorfrancis.com
Therapy in nuclear medicine practice has a long distinguished history. To use today's
phraseology, it is one of modern medicine's early “targeted therapies.” By its very nature …
phraseology, it is one of modern medicine's early “targeted therapies.” By its very nature …
Therapeutic interventions for Burkitt lymphoma in children
JU Okebe, N Skoetz, MM Meremikwu… - Cochrane Database …, 2011 - cochranelibrary.com
Background Burkitt lymphoma (BL) is an important cancer found mostly in children but
uncertainty remains as to the most effective form of management. In endemic areas, late …
uncertainty remains as to the most effective form of management. In endemic areas, late …
Hematopoietic cell transplantation for lymphomas
E Ayala, M Tomblyn - Cancer Control, 2011 - journals.sagepub.com
Background The heterogeneity of lymphomas results in numerous treatment options,
including both autologous and allogeneic hematopoietic cell transplantation. However, the …
including both autologous and allogeneic hematopoietic cell transplantation. However, the …
[HTML][HTML] Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index …
H Monjanel, E Deconinck, E Perrodeau… - Biology of Blood and …, 2011 - Elsevier
Single high-dose therapy (HDT) followed by autologous peripheral blood stem cell (PBSC)
support improves complete response and overall survival (OS) in untreated aggressive non …
support improves complete response and overall survival (OS) in untreated aggressive non …
Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with …
J Wang, P Zhan, J Ouyang, B Chen, R Zhou, Y Yang - Medical Oncology, 2011 - Springer
Randomized controlled trials (RCTs) have reported conflicting results on the impact of high-
dose chemotherapy with autologous hematopoietic stem cell transplantation (HDCT) as the …
dose chemotherapy with autologous hematopoietic stem cell transplantation (HDCT) as the …
[HTML][HTML] Autologous stem cell transplantation for aggressive lymphomas
G Visani, P Picardi, P Tosi, R Gonella… - … of Hematology and …, 2012 - ncbi.nlm.nih.gov
The role of high-dose therapy (HDT) followed by autologous stem cell transplantation
(ASCT) in the treatment armamentarium of aggressive B-and T-cell non-Hodgkin lymphoma …
(ASCT) in the treatment armamentarium of aggressive B-and T-cell non-Hodgkin lymphoma …